arrow
L

Lauren Véronèse

centre hospitalier universitaire de clermont-ferrand
H指数:18
被引数:1,053

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chromosomal Abnormalities, Drug Sensitivity and Resistance in Hematological Malignancies: A Comprehensive Overview by the Francophone Group of Hematological Cytogenetics (GFCH)

染色体异常、药物敏感性与耐药性在血液恶性肿瘤中的研究:法文血液细胞遗传学小组(GFCH)的综合概述

2026-10-050
OAAI
Intensive Chemotherapy With or Without Midostaurin in Adults ≥ 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study

老年(≥60岁)FLT3突变急性髓系白血病患者采用含或不含Midostaurin的强化化疗:一项FILO-DATAML-PETHEMA真实世界研究

2026-02-110
OAAI
Optimizing Wilms tumor 1 thresholds for measurable residual disease monitoring in acute myeloid leukemia: Improved sensitivity and concordance with nucleophosmin 1 in a single-center validation study

优化Wilms tumor 1阈值以监测急性髓系白血病中的可测量残留疾病:单中心验证研究中提高了与nucleophosmin 1的敏感性和一致性

Cancer
IF5.1
2025-10-260
PRE
Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study

Venetoclax和azacitidine用于NPM1或CBF AML在密集化疗后的分子复发:一项FILO研究

2025-08-210
OAAI
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
2024-08-090
OAAI
Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study
2024-05-300
PRE
The t(X;20)(q13;q13) translocation is a good prognostic factor in myeloid neoplasms: A report of 25 cases from the Groupe Francophone de Cytogenetique Hematologique
2024-04-130
OAAI
Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogenetique Hematologique (GFCH)

骨髓增殖性肿瘤,肥大细胞增多症和骨髓增生异常/骨髓增殖性肿瘤的处理中的细胞遗传学: 法语细胞遗传学血液学小组 (GFCH) 的指南

2023-10-010
PRE
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
2023-05-090
OAAI
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
2022-02-013
OAAI
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
2021-07-011
OAAI
Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort
2021-01-2526
PREAI